Pairwise comparison between the tumor grades indicated that the relative expression of the CDKN2A and CDKN2B transcripts was approximately 1.3-fold lower in grade IV glioblastoma compared with that in grade II astrocytoma (p<0.001) (Fig 1A and 1B). The gene discussed is CDKN2B; the disease is glioblastoma.